Cancer treatment has always been a balancing act—hit the tumor hard enough to kill it, but not so hard that the patient ...

Vivan Therapeutics is a pioneer in cancer treatment innovation through its novel approach to personalized medicine. By using ...

Doctors may soon be able to help women with early-stage breast cancer avoid unnecessary and aggressive treatments, thanks to ...

Leaders from The US Oncology Network and McKesson discuss how technology can enhance precision medicine and improve patient access to cutting-edge cancer treatments.

A new study reveals that chemotherapy-induced nerve pain arises from a stress response in immune cells that triggers inflammation and neurotoxicity.

FDA designates ZEN-3694 as an orphan drug, offering hope for patients with NUT carcinoma with no current approved therapies. The FDA has granted orphan drug designation to ZEN-3694, a novel oral ...

Of the 2.3 million women diagnosed annually with breast cancer worldwide, research shows more than half report having ...

Scientists reengineered chemo drug into spherical nucleic acids (SNAs), a globular form of DNA. Team tested the repackaged ...

Exousia Pro, Inc., a clinical-stage biotech company that specializes in the use of exomes to treat cancer and other illnesses ...

Scientists from King's College London have successfully applied a new technology that disarms one of the most potent weapons ...

Researchers found that lung and skin cancer patients who got COVID-19 vaccines reported significantly increased survival ...

Phung explained that prior response often guides selection: Patients who respond poorly to frontline therapy may move to CAR ...